Tool: DupCheckTool: DupCheck

www.DupCheck.org is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.


Project FlyerProject Flyer


Click here to download 
the NEWMEDS project flyer! 


ConsortiumConsortium
consortium teaser

QuicklinksQuicklinks
Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms




  Members Area
Username:
Password:



EU
IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

NEWMEDS Governance

Figure of NEWMEDS Governance structure:

figure of project governance

The Project Coordinator is the intermediary between the Innovative Medicine Initiative Joint Undertaking (IMI-JU) and the consortium in all scientific and industry related concerns. The Managing Entity is the second intermediary between the IMI-JU and the Consortium and is concerned with contractual and funding related matters concerning the participating academic institutions and SMEs. Together they form the Project Executive, with the assistance of the Deputy Coordinator and an appointed Legal Advsior. Each Work Package has an Academic Lead and a Deputy Lead from industry. They are jointly responsible for the Milestones and Deliverables of their WP and for engaging and communicating with all the partners in the project. The Project Governing Board is made up of one representative nominated by each of the participating institutions that make up the NEWMEDS consortium.

 

Project Governance